Mytos Announces $19M Series A Funding To Automate Human Cell Manufacturing And Further Accelerate Growth
Mytos Announces $19M Series A Funding To Automate Human Cell Manufacturing And Further Accelerate Growth
11/30/23, 1:10 PM
Location
Money raised
$19 million
Industry
biotechnology
Round Type
series a
Investors
Wing Vc, Iq Capital, Buckley Ventures
Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC.
Company Info
Location
35111 newark blvd
london, england, united kingdom
Additional Info
Mytos automates one of the last highly manual processes in biotech - growing human cells.
Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data.
Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists who have worked in top labs including at Imperial College, University of Cambridge and UCL. We're hiring now- visit our website to see open positions